Analyses of transcriptional regulation and signal transduction of sarcoplasmic reticulum Ca^<2+>

肌浆网Ca^<2>转录调控及信号转导分析

基本信息

  • 批准号:
    09670692
  • 负责人:
  • 金额:
    $ 2.11万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1998
  • 项目状态:
    已结题

项目摘要

Impaired Ca2+ handling in sarcoplasmic reticulum is a central mechanism that accounts for the cardiac dysfunction seen in doxorubicin induced-cardiomyopathy. We have recently demonstrated that mRNA expression for sarcoplasmic reticulum Ca2+-ATPase (SERCA2), the major Ca2+ transport protein in sarcoplasmic reticulum, is markedly decreased in doxorubicin induced-failing hearts.The purpose of this study was to clarify the molecular mechanisms by which doxorubicin down-regulates SBRCA2 gene. N-acetylcysteine ; an anti-oxidant, protected SERCA2 mRNA levels from a decrease induced by doxorubicin in cultured rat cardiac myocytes, and the concentration of hydrogen peroxide was 3-fold higher than basal level, suggesting that hydrogen peroxidels an intracellular mediator of doxorubicin. Luciferase reporter assay revealed that 5' flanking sequence from -284 to -72 bp of SERCA2 gene has a doxorubicin responsible element. Of the transcription factors that have putative binding motifs in the 5' flanking -284 to -72 bp region of SERCA2 gene, the expression of Egr-1 mRNA was markedly increased after doxorubicin administration. Over-expression of Egr-1 significantly diminished the transcription of SERCA2 gene. Additionally, antisense oligonucleotides against Egr-1 rescued the doxorubicin induced-decrease of SERCA2 mRNA expression. These results suggest that Egr-1 is a transcriptional inhibitor of SERCA2 gene under doxorubicin administration. Finally, we clarified kinases which controls Egr-1 and, thus SERCA2 genes. Three MAP kinases ; p44/42 MAP kinase, p38 MAP kinase and SAPK/JNK were all activated by doxorubicin. PD98059, a specific blocker of p44/42 MAP kinase kinase, had a preventive effect on the doxorubicin induced-increase of Egr- 1 gene and the decrease of SERCA2 gene.Our studies indicate that reactive oxygen intermediates, transcription factor Egr-1 and p44/42 MAP kinase have a pivotal role for the transcriptional regulation of SERCA2 gene in doxorubicin signaling pathway.
肌浆网中Ca 2+处理受损是多柔比星诱导的心肌病中观察到的心功能不全的中心机制。本研究旨在阐明阿霉素下调心肌肌浆网Ca ~(2+)-ATP酶(sarcoplasmic reticulum Ca ~(2+)-ATPase,SERCA_2)基因表达的分子机制。乙酰半胱氨酸;在培养的大鼠心肌细胞中,一种抗氧化剂,保护SERCA 2 mRNA水平免受阿霉素诱导的降低,并且过氧化氢的浓度比基础水平高3倍,表明过氧化氢是阿霉素的细胞内介质。荧光素酶报告基因分析表明SERCA 2基因5'端-284 ~-72 bp的侧翼序列具有阿霉素的反应元件。在SERCA 2基因5'端-284 ~-72 bp区域具有结合基序的转录因子中,阿霉素诱导Egr-1 mRNA表达显著增加。Egr-1的过表达显著降低了SERCA 2基因的转录。此外,针对Egr-1的反义寡核苷酸挽救了阿霉素诱导的SERCA 2 mRNA表达的降低。这些结果表明,Egr-1是阿霉素给药下SERCA 2基因的转录抑制剂。最后,我们阐明了控制Egr-1和SERCA 2基因的激酶。三种MAP激酶:p44/42 MAP激酶、p38 MAP激酶和SAPK/JNK均被阿霉素激活。p44/42 MAP激酶的特异性阻断剂PD 98059对阿霉素诱导的Egr- 1基因表达的增加和SERCA 2基因表达的减少具有预防作用,提示活性氧中间产物、转录因子Egr-1和p44/42 MAP激酶在阿霉素信号通路中对SERCA 2基因的转录调控起关键作用。

项目成果

期刊论文数量(28)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yoshio Ohyama: "Molecular cloning of rat klotho cDNA : Markedly decreased expression of klotho by acute inflammatory stress" Blochem Biophys Res Commun. 251. 920-925 (1998)
Yoshio Ohyama:“大鼠 klotho cDNA 的分子克隆:急性炎症应激显着降低 klotho 的表达”Blochem Biophys Res Commun。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masahiro Inoue: "Impaired expression of brain nctriuretic peptide gene in deabetic rats with myocardial infarction" Exp Clin Endocrinol Diabetes. 106. 483-487 (1998)
Masahiro Inoue:“患有心肌梗塞的糖尿病大鼠脑钠尿肽基因表达受损”Exp Clin Endocrinol Diabetes。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kanda T,Koike H,Arai M,Wilson JE,Carthy CM,Yang D,McManus BM,Nagai R,Kobayashi I.: "Increased severity of viral myocarditis in mice lacking lymphocyte maturation" Int J Cardiol. 68. 13-22 (1999)
Kanda T,Koike H,Arai M,Wilson JE,Carthy CM,Yang D,McManus BM,Nagai R,Kobayashi I.:“缺乏淋巴细胞成熟的小鼠病毒性心肌炎的严重程度增加”Int J Cardiol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Arai M,Tomaru K,Takizawa T,Sekiguchi K,Yokoyama T,Suzuki T,Nagai R.: "Sarcoplasmic reticulum genes are selectively down-regulated in cardiomyopathy produced by doxorubicin in rabbits" J Mol Cell Cardiol. 30. 243-254 (1998)
Arai M、Tomaru K、Takizawa T、Sekiguchi K、Yokoyama T、Suzuki T、Nagai R.:“兔多柔比星引起的心肌病中肌浆网基因选择性下调”J Mol Cell Cardiol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ohyama Y,Kurabayashi M,Masuda H,Nakamura T,Aihara Y,Kaname T,Arai M,Aizawa H,Matsumura Y,Kuro-o M,Nabeshima Y,Nagai R.: "Molecular cloning of rat klotho cDNA : Markedly decreased expression of klotho by acute inflammatory stress" Biochem Biophys Res Commu
Ohyama Y,Kurabayashi M,Masuda H,Nakamura T,Aihara Y,Kaname T,Arai M,Aizawa H,Matsumura Y,Kuro-o M,Nabeshima Y,Nagai R.:“大鼠 klotho cDNA 的分子克隆:表达显着降低
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ARAI Masashi其他文献

ARAI Masashi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ARAI Masashi', 18)}}的其他基金

Analysis of Corporate Strategy and Effects on Competition through Consortium Based Standardization
通过基于联盟的标准化分析公司战略和对竞争的影响
  • 批准号:
    21830121
  • 财政年份:
    2009
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Development of novel therapeutic strategy for heart failure by improving Ca2+ transport function of sarcoplasmic reticulum
通过改善肌浆网Ca2+转运功能开发心力衰竭新治疗策略
  • 批准号:
    15590717
  • 财政年份:
    2003
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of novel heart failure therapy by using gene transfer into cardiac myocytes
利用基因转移至心肌细胞开发新型心力衰竭疗法
  • 批准号:
    13832002
  • 财政年份:
    2001
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Transcriptional regulation of the SERCA2 gene during the development of heart failure
SERCA2 基因在心力衰竭发展过程中的转录调控
  • 批准号:
    11838001
  • 财政年份:
    1999
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The pathophysiological role of calsequestrin for the development of cardiac hypertrophy
calsequestrin 对心脏肥大发展的病理生理作用
  • 批准号:
    07670754
  • 财政年份:
    1995
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

Visnagin选择性保护doxorubicin诱发的细胞死亡的代谢机制
  • 批准号:
    81872447
  • 批准年份:
    2018
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
Sorafenib-Doxorubicin脂质体对超声引导下肝癌射频消融治疗效果影响及机制的研究
  • 批准号:
    81501489
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
转录因子EB (TFEB) 诱导的自噬通路分子在Doxorubicin诱导的心肌重构中的作用研究
  • 批准号:
    81570243
  • 批准年份:
    2015
  • 资助金额:
    62.0 万元
  • 项目类别:
    面上项目
蒽环类药物与内源性靶分子细胞毒性作用机制的亚细胞药代动力学研究
  • 批准号:
    20905037
  • 批准年份:
    2009
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Individualized medicine to predict and prevent chemotherapy-related heart failure
预测和预防化疗相关心力衰竭的个体化药物
  • 批准号:
    10714111
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
Characterization of TRPC6 to predict and prevent chemotherapy-related heart failure
TRPC6 的表征可预测和预防化疗相关心力衰竭
  • 批准号:
    10705329
  • 财政年份:
    2022
  • 资助金额:
    $ 2.11万
  • 项目类别:
Prevention of Heart Failure induced by Doxorubicin with Early Administration of Dexrazoxane
早期给予右雷佐生预防阿霉素诱发的心力衰竭
  • 批准号:
    10334966
  • 财政年份:
    2020
  • 资助金额:
    $ 2.11万
  • 项目类别:
Prevention of Heart Failure induced by Doxorubicin with Early Administration of Dexrazoxane
早期给予右雷佐生预防阿霉素诱发的心力衰竭
  • 批准号:
    10616610
  • 财政年份:
    2020
  • 资助金额:
    $ 2.11万
  • 项目类别:
Multiplexed Imaging of Energy Metabolism in Murine Models of Heart Failure
心力衰竭小鼠模型能量代谢的多重成像
  • 批准号:
    9330905
  • 财政年份:
    2016
  • 资助金额:
    $ 2.11万
  • 项目类别:
Multiplexed Imaging of Energy Metabolism in Murine Models of Heart Failure
心力衰竭小鼠模型能量代谢的多重成像
  • 批准号:
    9096879
  • 财政年份:
    2016
  • 资助金额:
    $ 2.11万
  • 项目类别:
Multiplexed Imaging of Energy Metabolism in Murine Models of Heart Failure
心力衰竭小鼠模型能量代谢的多重成像
  • 批准号:
    8753247
  • 财政年份:
    2014
  • 资助金额:
    $ 2.11万
  • 项目类别:
Multiplexed Imaging of Energy Metabolism in Murine Models of Heart Failure
心力衰竭小鼠模型能量代谢的多重成像
  • 批准号:
    8920164
  • 财政年份:
    2014
  • 资助金额:
    $ 2.11万
  • 项目类别:
Cruciferous Dithiolethiones for Chronic Heart Failure: Signaling Mechanisms
十字花科二硫代硫酮治疗慢性心力衰竭:信号机制
  • 批准号:
    8770355
  • 财政年份:
    2014
  • 资助金额:
    $ 2.11万
  • 项目类别:
SD COBRE: NOVEL MECHANISMS OF DOXORUBIN-INDUCED HEART FAILURE
SD COBRE:阿霉素诱发心力衰竭的新机制
  • 批准号:
    8360550
  • 财政年份:
    2011
  • 资助金额:
    $ 2.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了